FI852990A0 - Saosom antiarytmiska aemnen anvaendbara 2,5-pyrrolidindionderivat. - Google Patents
Saosom antiarytmiska aemnen anvaendbara 2,5-pyrrolidindionderivat.Info
- Publication number
- FI852990A0 FI852990A0 FI852990A FI852990A FI852990A0 FI 852990 A0 FI852990 A0 FI 852990A0 FI 852990 A FI852990 A FI 852990A FI 852990 A FI852990 A FI 852990A FI 852990 A0 FI852990 A0 FI 852990A0
- Authority
- FI
- Finland
- Prior art keywords
- pyrrolidindionderivat
- antiarytmiska
- aemnen
- saosom
- anvaendbara
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Photolithography (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Lubricants (AREA)
- Treatment Of Water By Ion Exchange (AREA)
- Plural Heterocyclic Compounds (AREA)
- Suspension Of Electric Lines Or Cables (AREA)
- Professional, Industrial, Or Sporting Protective Garments (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63763384 | 1984-08-03 | ||
US06/637,633 US4554353A (en) | 1984-08-03 | 1984-08-03 | 2,5-Pyrrolidinedione derivatives useful as antiarrhythmic agents |
Publications (4)
Publication Number | Publication Date |
---|---|
FI852990A0 true FI852990A0 (fi) | 1985-08-02 |
FI852990L FI852990L (fi) | 1986-02-04 |
FI80876B FI80876B (fi) | 1990-04-30 |
FI80876C FI80876C (fi) | 1990-08-10 |
Family
ID=24556766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI852990A FI80876C (fi) | 1984-08-03 | 1985-08-02 | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2,5-pyrrolidindionderivat. |
Country Status (18)
Country | Link |
---|---|
US (1) | US4554353A (fi) |
EP (1) | EP0170281B1 (fi) |
JP (1) | JPS6143164A (fi) |
AT (1) | ATE53575T1 (fi) |
AU (1) | AU581914B2 (fi) |
CA (1) | CA1270833C (fi) |
DE (1) | DE3578172D1 (fi) |
DK (1) | DK163661C (fi) |
ES (1) | ES8703421A1 (fi) |
FI (1) | FI80876C (fi) |
GR (1) | GR851890B (fi) |
IE (1) | IE60110B1 (fi) |
IL (1) | IL75985A (fi) |
NO (1) | NO166529C (fi) |
NZ (1) | NZ212955A (fi) |
PH (1) | PH20948A (fi) |
PT (1) | PT80905B (fi) |
ZA (1) | ZA855860B (fi) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD973876S1 (en) * | 2020-03-18 | 2022-12-27 | Stephen A. Young | Blood sampling device |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH306905A (de) * | 1951-09-11 | 1955-04-30 | Ciba Geigy | Verfahren zur Herstellung eines neuen Dioxopyrrolidins. |
US2666060A (en) * | 1951-09-11 | 1954-01-12 | Ciba Pharm Prod Inc | 1, 3-bisaminoalkyl-3-phenyl-2, 5-dioxopyrrolidines |
FR1079802A (fr) * | 1952-02-26 | 1954-12-02 | Parke Davis & Co | Fabrication de dérivés de la succinimide |
-
1984
- 1984-08-03 US US06/637,633 patent/US4554353A/en not_active Expired - Fee Related
-
1985
- 1985-08-01 AU AU45693/85A patent/AU581914B2/en not_active Ceased
- 1985-08-01 CA CA487944A patent/CA1270833C/en not_active Expired
- 1985-08-01 DE DE8585109680T patent/DE3578172D1/de not_active Expired - Fee Related
- 1985-08-01 NZ NZ212955A patent/NZ212955A/en unknown
- 1985-08-01 PH PH32590A patent/PH20948A/en unknown
- 1985-08-01 EP EP85109680A patent/EP0170281B1/en not_active Expired - Lifetime
- 1985-08-01 IL IL75985A patent/IL75985A/xx not_active IP Right Cessation
- 1985-08-01 AT AT85109680T patent/ATE53575T1/de active
- 1985-08-01 GR GR851890A patent/GR851890B/el unknown
- 1985-08-02 JP JP60171008A patent/JPS6143164A/ja active Granted
- 1985-08-02 FI FI852990A patent/FI80876C/fi not_active IP Right Cessation
- 1985-08-02 DK DK353785A patent/DK163661C/da not_active IP Right Cessation
- 1985-08-02 IE IE193285A patent/IE60110B1/en not_active IP Right Cessation
- 1985-08-02 NO NO853069A patent/NO166529C/no unknown
- 1985-08-02 ES ES545870A patent/ES8703421A1/es not_active Expired
- 1985-08-02 PT PT80905A patent/PT80905B/pt not_active IP Right Cessation
- 1985-08-02 ZA ZA855860A patent/ZA855860B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DK353785D0 (da) | 1985-08-02 |
IL75985A (en) | 1988-07-31 |
GR851890B (fi) | 1985-12-09 |
AU4569385A (en) | 1986-02-06 |
DK163661B (da) | 1992-03-23 |
NO166529C (no) | 1991-08-07 |
EP0170281A2 (en) | 1986-02-05 |
JPS6143164A (ja) | 1986-03-01 |
NO166529B (no) | 1991-04-29 |
FI80876C (fi) | 1990-08-10 |
ES545870A0 (es) | 1987-02-16 |
ZA855860B (en) | 1986-10-29 |
EP0170281A3 (en) | 1986-06-25 |
NZ212955A (en) | 1988-03-30 |
IE60110B1 (en) | 1994-06-01 |
JPH0566942B2 (fi) | 1993-09-22 |
FI852990L (fi) | 1986-02-04 |
PT80905B (pt) | 1987-09-30 |
NO853069L (no) | 1986-02-04 |
PH20948A (en) | 1987-06-10 |
DK163661C (da) | 1992-08-24 |
ATE53575T1 (de) | 1990-06-15 |
DE3578172D1 (de) | 1990-07-19 |
AU581914B2 (en) | 1989-03-09 |
CA1270833A (en) | 1990-06-26 |
IE851932L (en) | 1986-02-03 |
FI80876B (fi) | 1990-04-30 |
IL75985A0 (en) | 1985-12-31 |
ES8703421A1 (es) | 1987-02-16 |
PT80905A (en) | 1985-09-01 |
DK353785A (da) | 1986-02-04 |
US4554353A (en) | 1985-11-19 |
CA1270833C (en) | 1990-06-26 |
EP0170281B1 (en) | 1990-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2070660B1 (es) | Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales. | |
CA2009735A1 (en) | Insecticidally active nitro compounds | |
NO163331C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 6,7-disubstituerte 1-cyklopropyl-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyrer. | |
IT1212143B (it) | Composizione ad attivita'tricogena. | |
GB8720910D0 (en) | Antiarrhythmic agents | |
ATE41773T1 (de) | 4,5-dihydro-4-oxo-2((2-transphenylcyclopropyl)amino>-3-furancarbonsaeuren und derivate davon. | |
EG17752A (en) | Benzoylurea derivatives | |
EP0470431A3 (en) | Use of phosphomycin and the pharmaceutically acceptable salts thereof as a topical cicatrizer | |
FI852990L (fi) | Saosom antiarytmiska aemnen anvaendbara 2,5-pyrrolidindionderivat. | |
FI901277A0 (fi) | 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ. | |
TR23271A (tr) | En asagi % 95.5 safliginda p-ksilol'un kazanilmasina mahsus usul | |
ES2001042A6 (es) | Un metodo para la preparacion de acidos 5,6-dialcoxiantranilicos | |
RO94553A (ro) | Compozitie insecticida | |
SU1319521A1 (ru) | 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность | |
SU1483894A1 (ru) | ДИГИДРОХЛОРИД 1-ДИЭТИЛАМИНОЭТИЛ-2-ФЕНИЛИМИДАЗО[1,2-а]БЕНЗИМИДАЗОЛА, ОБЛАДАЮЩИЙ ГИПОТЕНЗИВНЫМ И АНТИАРИТМИЧЕСКИМ ДЕЙСТВИЕМ | |
YU47871B (sh) | Derivati aminokiselina | |
SU1455625A1 (ru) | 1-(1,3-диметилксантинил-8-тио)-3-морфолинопропанол-2, проявляющий гипотензивную и противоаритмическую активность | |
SU1617908A1 (ru) | β-ДИЭТИЛАМИНОЭТИЛОВЫЙ ЭФИР 2,4-ДИМЕТИЛПИРАЗОЛО[1,5-а]БЕНЗИМИДАЗОЛИЛ-3-КАРБОНОВОЙ КИСЛОТЫ ГИДРОХЛОРИД, ОБЛАДАЮЩИЙ АНТИАРИТМИЧЕСКОЙ АКТИВНОСТЬЮ | |
SU1221874A1 (ru) | 1,1-Этилиденди-(5-нитро-2-фуроиламин), проявляющий противомикробную и противовоспалительную активность | |
IT8419056A0 (it) | Procedimento per l'isolamento di l-amminoacidi. | |
SU1302661A1 (ru) | 3-(3,5-Диметилпиразолил-1)-6-(2-карбэтокси-1-метилэтилиден-1)гидразинопиридазин, обладающий противовоспалительной и противомикробной активностью | |
SU1269465A1 (ru) | Способ получения 2-анилино-7-гидрокси-6н-1,3,4-тиадиазепинов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: G.D. SEARLE & CO. |